Novartis CEO Signals Bold M&A Plans Following $12 Billion Avidity Biosciences Deal
Novartis is making waves in the pharmaceutical industry with its latest move to acquire Avidity Biosciences for approximately $12 billion,
Novartis Just Dropped $12 Billion on a Biotech Firm — This Could Change Medicine Forever
Novartis Makes a Jaw-Dropping $12 Billion Move Swiss pharmaceutical giant Novartis shocked the biotech world by agreeing to acquire U.S.-based